Baird Has Just Reaffirmed $32 Target Price Per Share on Wright Medical Group (NASDAQ:WMGI) stock, While They’ve Also Reiterated Their Outperform Rating

August 10, 2018 - By Margaret Guttierez

Wright Medical Group N.V. (NASDAQ:WMGI) Logo

Wright Medical Group (NASDAQ:WMGI) Rating Reaffirmed

Baird now has a $32 target price on the $2.97 billion market cap company or 14.12 % upside potential. In an analyst report issued to clients on Thursday, 9 August, Wright Medical Group (NASDAQ:WMGI) shares have had their Outperform Rating reconfirmed by expert analysts at Baird.

Wright Medical Group N.V. (NASDAQ:WMGI) Ratings Coverage

Among 9 analysts covering Wright Medical Group (NASDAQ:WMGI), 8 have Buy rating, 0 Sell and 1 Hold. Therefore 89% are positive. Wright Medical Group has $35 highest and $25 lowest target. $30.13’s average target is 7.45% above currents $28.04 stock price. Wright Medical Group had 17 analyst reports since February 12, 2018 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, June 13 by Guggenheim. The firm earned “Outperform” rating on Wednesday, February 28 by BMO Capital Markets. The company was maintained on Wednesday, February 28 by Robert W. Baird. On Thursday, June 21 the stock rating was maintained by Leerink Swann with “Outperform”. The rating was maintained by Cantor Fitzgerald on Thursday, June 21 with “Buy”. Cantor Fitzgerald maintained the stock with “Buy” rating in Monday, June 11 report. The firm has “Buy” rating given on Monday, March 12 by Cantor Fitzgerald. The stock of Wright Medical Group N.V. (NASDAQ:WMGI) has “Buy” rating given on Thursday, August 9 by Bank of America. Cantor Fitzgerald maintained Wright Medical Group N.V. (NASDAQ:WMGI) on Monday, April 30 with “Buy” rating. The stock of Wright Medical Group N.V. (NASDAQ:WMGI) earned “Buy” rating by Cantor Fitzgerald on Monday, May 21.

The stock decreased 0.36% or $0.1 during the last trading session, reaching $28.04. About 55,453 shares traded. Wright Medical Group N.V. (NASDAQ:WMGI) has declined 9.52% since August 10, 2017 and is downtrending. It has underperformed by 22.09% the S&P500.

Wright Medical Group N.V., a medical device company, designs, makes, markets, and sells extremities and biologics products.in the United States, Europe, the Middle East, Africa, and internationally. The company has market cap of $2.97 billion. The firm offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It currently has negative earnings. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries.

More notable recent Wright Medical Group N.V. (NASDAQ:WMGI) news were published by: Benzinga.com which released: “Benzinga’s Top Upgrades, Downgrades For August 9, 2018” on August 09, 2018, also Benzinga.com with their article: “40 Stocks Moving In Thursday’s Pre-Market Session” published on August 09, 2018, Benzinga.com published: “68 Stocks Moving In Thursday’s Mid-Day Session” on August 09, 2018. More interesting news about Wright Medical Group N.V. (NASDAQ:WMGI) were released by: Streetinsider.com and their article: “Wright Medical (WMGI) PT Raised to $32 at RBC Capital” published on August 09, 2018 as well as Nasdaq.com‘s news article titled: “Detailed Research: Economic Perspectives on Veritiv, Wright Medical Group NV, Ollie’s Bargain Outlet, Compass …” with publication date: July 25, 2018.

Wright Medical Group N.V. (NASDAQ:WMGI) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.